These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 28948652)

  • 1. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
    Sherwin J; Heath T; Watt K
    Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
    Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
    Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
    Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
    Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
    J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.
    Shekar K; Roberts JA; Welch S; Buscher H; Rudham S; Burrows F; Ghassabian S; Wallis SC; Levkovich B; Pellegrino V; McGuinness S; Parke R; Gilder E; Barnett AG; Walsham J; Mullany DV; Fung YL; Smith MT; Fraser JF
    BMC Anesthesiol; 2012 Nov; 12():29. PubMed ID: 23190792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
    Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
    Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.
    Wang Y; Li Z; Chen W; Yan G; Wang G; Lu G; Chen C
    J Clin Pharm Ther; 2021 Jun; 46(3):754-761. PubMed ID: 33476064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
    Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
    J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.
    Wi J; Noh H; Min KL; Yang S; Jin BH; Hahn J; Bae SK; Kim J; Park MS; Choi D; Chang MJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic review.
    Cree ML; Abdul-Aziz MH; Schlapbach LJ; Roberts JA; Parker SL
    Int J Antimicrob Agents; 2024 Oct; 64(4):107311. PubMed ID: 39197687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Extracorporeal Membrane Oxygenation in Adults: A Literature Review.
    Tukacs M
    AACN Adv Crit Care; 2018; 29(3):246-258. PubMed ID: 30185491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation.
    Jaruratanasirikul S; Vattanavanit V; Samaeng M; Nawakitrangsan M; Sriwiriyajan S
    Clin Drug Investig; 2019 Aug; 39(8):787-798. PubMed ID: 31124013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of extracorporeal membrane oxygenation on pharmacokinetics of antimicrobial drugs: recent progress and recommendations].
    Zhang Y; Zeng Z; Zhang Q; Ou Q; Chen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):793-800. PubMed ID: 34134970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
    Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
    Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.